- Home
- QNCX vs OM Comparison
QNCX vs OM Comparison
Compare QNCX & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- OM
- Stock Information
- Founded
- QNCX 2012
- OM 2003
- Country
- QNCX United States
- OM United States
- Employees
- QNCX N/A
- OM N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- QNCX Health Care
- OM Health Care
- Exchange
- QNCX Nasdaq
- OM Nasdaq
- Market Cap
- QNCX 44.0M
- OM 50.5M
- IPO Year
- QNCX 2019
- OM 2020
- Fundamental
- Price
- QNCX $1.03
- OM $15.88
- Analyst Decision
- QNCX Strong Buy
- OM Buy
- Analyst Count
- QNCX 5
- OM 2
- Target Price
- QNCX $8.00
- OM $29.50
- AVG Volume (30 Days)
- QNCX 511.8K
- OM 136.5K
- Earning Date
- QNCX 05-16-2025
- OM 05-07-2025
- Dividend Yield
- QNCX N/A
- OM N/A
- EPS Growth
- QNCX N/A
- OM N/A
- EPS
- QNCX N/A
- OM N/A
- Revenue
- QNCX N/A
- OM $115,273,000.00
- Revenue This Year
- QNCX N/A
- OM $8.98
- Revenue Next Year
- QNCX N/A
- OM $12.74
- P/E Ratio
- QNCX N/A
- OM N/A
- Revenue Growth
- QNCX N/A
- OM N/A
- 52 Week Low
- QNCX $0.51
- OM $5.85
- 52 Week High
- QNCX $2.45
- OM $78.30
- Technical
- Relative Strength Index (RSI)
- QNCX 38.67
- OM 71.33
- Support Level
- QNCX $0.98
- OM $11.19
- Resistance Level
- QNCX $1.16
- OM $12.79
- Average True Range (ATR)
- QNCX 0.09
- OM 1.18
- MACD
- QNCX 0.01
- OM 0.34
- Stochastic Oscillator
- QNCX 22.22
- OM 92.12
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.